It is noteworthy that the majority of biopsy-positive patients with a PSA level in the gray zone (4–10 ng/mL) have a pathological diagnosis of a Gleason score of ≤6 clinically limited tumors that are clinically insignificant prostate cancers (5, 6). This evidence concerns the gene KLK3 and prostate cancer.